BridgeMD
New treatment option for to Assess Effect of Peer-led Education
Official title Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculosis in South Omo and Ari Zone, Southern Ethiopia
ClinicalTrials.gov ID: NCT07387601
What this study is testing
What is peer-led education?
peer-led education is an investigational medicine, being studied as a potential treatment for to assess effect of peer-led education.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study might come up with valuable findings to address poor treatment outcome, poor quality of life, disability score and depressive symptoms. The findings may also be decreased health professional workload.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults with new drug-susceptible pulmonary TB who will be diagnosed in bacteriological diagnostic methods
- not participating in similar study,
- mentally capable to provide consent,
- physically capable of following the intervention.
You likely can't join if
- Seriously ill patients at the time of screening or enrollment
- Tuberculosis patients with a known plan to be transferred out of the study sites
The study team makes the final eligibility decision.
Where it's taking place
- Jinka, Southern Ethiopia, Ethiopia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jinka, Southern Ethiopia, Ethiopia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.